State Street
AKCA

State Street’s Akcea Therapeutics Inc AKCA Stock Holding History

State Street’s Portfolio AKCA Stock Details AKCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-308,217
Closed -$5.59M – 3951
2020
Q3 		$5.59M Sell
308,217
-10,043
-3% -$142K ﹤0.01% 2725
2020
Q2 		$4.36M Sell
318,260
-358,211
-53% -$5.53M ﹤0.01% 2822
2020
Q1 		$9.67M Buy
676,471
+11,861
+2% +$195K ﹤0.01% 2305
2019
Q4 		$11.3M Buy
664,610
+47,729
+8% +$888K ﹤0.01% 2465
2019
Q3 		$9.49M Sell
616,881
-108,778
-15% -$2.32M ﹤0.01% 2494
2019
Q2 		$17M Buy
725,659
+145,802
+25% +$3.6M ﹤0.01% 2214
2019
Q1 		$16.4M Buy
579,857
+252,050
+77% +$7.34M ﹤0.01% 2174
2018
Q4 		$9.88M Sell
327,807
-27,931
-8% -$783K ﹤0.01% 2438
2018
Q3 		$12.5M Buy
355,738
+95,729
+37% +$2.9M ﹤0.01% 2459
2018
Q2 		$6.17M Sell
260,009
-300
-0.1% -$7.16K ﹤0.01% 2764
2018
Q1 		$6.66M Buy
260,309
+3,685
+1% +$79.3K ﹤0.01% 2648
2017
Q4 		$4.46M Buy
256,624
+91,996
+56% +$1.8M ﹤0.01% 2840
2017
Q3 		$4.55M Buy
+164,628
New +$3.05M ﹤0.01% 2844

State Street's AKCA Position: Q4 2020 in Review

State Street sold out of Akcea Therapeutics Inc (AKCA) in Q4 2020, closing a stake of 308,217 shares — an estimated $5.59M sold.

State Street first reported a position in AKCA in Q3 2017 and held it in 13 quarters. The position peaked at $17M in Q2 2019. 0 funds tracked by Wall St. Rank hold AKCA as of Q4 2020.

  • State Street reported no remaining Akcea Therapeutics Inc position as of Q4 2020 after selling out during the quarter.
  • State Street sold 308,217 Akcea Therapeutics Inc shares in Q4 2020, an estimated $5.59M.
  • State Street first reported a position in Akcea Therapeutics Inc in Q3 2017 and held it in 13 quarters.
  • State Street's Akcea Therapeutics Inc position peaked at $17M in Q2 2019.
  • 0 funds tracked by Wall St. Rank held Akcea Therapeutics Inc as of Q4 2020.

Based on State Street's 13F filing for Q4 2020, filed 16 Feb 2021.